The U.S. Government Is Investing $2 Billion in the Quantum Computing Space, But Did It Miss the Best Stock to Buy?

The U.S. government plans to provide more than $2 billion in incentives and equity investments to quantum computing firms under the CHIPS and Science Act, including $1 billion each for IBM's Anderon and the government-backed quantum manufacturing push. GlobalFoundries is set to receive $375 million and a roughly 1% Commerce Department equity stake, while seven other quantum companies will also get investments. IonQ was notably left out despite its leadership in trapped-ion fidelity and its planned acquisition of SkyWater Technology, making the article constructive for the sector but only modestly market-moving overall.

Analysis

This is less a clean sector bullish event than a targeted industrial-policy signal: the winners are the companies that can translate government sponsorship into manufacturing capacity, not the ones with the best lab metrics. The first-order beneficiaries are IBM and GFS because public capital reduces funding risk and de-risks domestic supply-chain buildout; the second-order winner is SKYT if the acquisition closes, since control of foundry capacity becomes strategically more valuable than standalone IP. The market should also start pricing a “national champion” premium for firms that can be embedded in onshore quantum infrastructure, even if near-term revenues remain immaterial.

IONQ’s omission matters more as a relative signal than an absolute one. If the government is effectively picking an execution path around manufacturing and ecosystem control, then the competitive moat shifts from pure fidelity claims toward vertical integration, government access, and time-to-scale. That means IONQ can still outperform operationally, but its valuation multiple may face pressure if investors conclude it is the best technology with the weakest policy tailwind.

The contrarian risk is that this announcement front-loads optimism into a space with long commercialization lags and uncertain procurement conversion. Quantum remains a years-long story, so any retracement in political enthusiasm, budget reallocation, or delayed equity-stake execution could unwind the move quickly. The fastest reversal catalyst would be evidence that the incentives are mostly symbolic or that the chosen companies cannot convert subsidies into credible pilot-to-production milestones within 6-12 months.

Key Decisions for Investors

• Relative-value long IONQ / short QBTS for 3-6 months: own the highest-quality technical platform while fading names likely to trade mostly on subsidy optics; risk is that IONQ’s policy exclusion remains a valuation overhang.
• Buy GFS on pullbacks for a 6-12 month horizon: the equity-stake structure reduces left-tail financing risk and could support a rerating as an onshore quantum manufacturing proxy; trim if the stock rallies beyond the implied subsidy value before LOI conversion.
• Event-driven long SKYT against a basket short of weaker quantum micro-caps if acquisition terms remain intact: the strategic premium should accrue to foundry control, but abandon if regulatory or integration risk rises.
• Avoid chasing the initial pop in IBM; use strength to sell covered calls or reduce exposure after the headline effect fades, since the economics here are policy-supported but unlikely to move near-term EPS materially.
• If IONQ sells off on the omission, consider staged entries on weakness rather than momentum buying: the setup is better as a long-duration quality trade than a short-term policy beneficiary, with upside only if it later secures explicit federal or defense-linked contracts.